Spicyip compulsory licensing

News Will defining crypto assets as capital assets have an impact on their operation in India? Guest Author 1 day ago. News Addressing the taxation and money laundering concerns associated with crypto-assets. Guest Author 4 days ago. News Regulations to check Facebook should focus on safer algorithms, not content removal. Nishant Kauntia December 23, News New Drone Rules: A mature regulatory regime for drone-based deliveries.

Guest Author December 15, Share Tweet. You May Also Like. Sneha Johari March 23, Medianama June 9, News Ola, Uber drivers say they are exhausted, fear being wiped out.

Soumyarendra Barik February 24, Aroon Deep April 24, I agree to receive newsletters from MediaNama. Please enter all required fields. Correct invalid entries. Subscribe to our daily newsletter. Please enter all required fields Correct invalid entries. No spam, ever. The application goes on to quote studies that indicate the Baricitinib in combination with Remdesivir is more effective for patients with Covid 19, as compared to Remdesivir alone, with possibly less side effects as well see Para It is unclear whether Eli Lilly is the exclusive licensee or not.

This time however, Natco is not going the Section 84 route, but rather is taking the Section 92 route. Needless to say, there is clearly an on-going emergency. Natco relies on Form 27 data to show that Olumiant is not manufactured in India, that less than tablets were imported in and , and that the average cost per tablet is approximately INR In terms of other formalities, Natco seems all set. For current purposes, Natco says they are willing to make the tablets available at prices between INR 15 per tablet, to INR 30 per tablet depending on the dosage, though they state that they will inform the Controller later as to the quantity that they can make available.

So next time a foot tapping number is being broadcast by your favourite FM channel, take a moment and thank Justice Sinha. Sorry to be commenting on tis post so late in the day but I wanted to discuss a couple of points that you made in this post.

For e. Anyway I must admit I have not read the judgment in this case and will accept your word as the last word until I actually get down to reading the judgment. FIrst of all, Please forgive my ignorance on matters related to music copyrights.

I am lapping up on these issues more now as I mooting an idea of a startup in this area. Can now anyone approach T-series for compulsory license to exploit its content digitally. I am assuming one would have to go to T-series because t-series is not a party to the PPL society and collects its own royalties. Notify me of followup comments via e-mail.